15

Riżultat(i)

Kelma (kelmiet)
Tip ta' pubblikazzjoni
Qasam tematiku
Awtur
Kelma għat-tiftix
Data

ITER

26-09-2017

The International Thermonuclear Experimental Reactor (ITER) project is a major global collaborative scientific experiment aimed at demonstrating the feasibility of nuclear fusion as an unlimited and relatively clean source of energy. The EU Member States participate by virtue of their membership of Euratom. Work on the site in France (Cadarache) began in 2007, but since then the expected final cost and year of completion have been revised upwards a number of times. It is now hoped that 'first plasma ...

The International Thermonuclear Experimental Reactor (ITER) project is a major global collaborative scientific experiment aimed at demonstrating the feasibility of nuclear fusion as an unlimited and relatively clean source of energy. The EU Member States participate by virtue of their membership of Euratom. Work on the site in France (Cadarache) began in 2007, but since then the expected final cost and year of completion have been revised upwards a number of times. It is now hoped that 'first plasma', the point at which the ITER device is deemed operational, will be achieved by 2025.

Research for PECH Committee - Small scale fisheries and “Blue Growth” in the EU

18-04-2017

This study presents an overview of Blue Growth emerging industries and investigates the linkages with the traditional maritime activity of fisheries with emphasis on small-scale fisheries. Positive synergies are investigated as well as possible opportunities (and threats) that Blue Growth can or should offer to small-scale fisheries and coastal communities in the context of economic growth, employment and innovation.

This study presents an overview of Blue Growth emerging industries and investigates the linkages with the traditional maritime activity of fisheries with emphasis on small-scale fisheries. Positive synergies are investigated as well as possible opportunities (and threats) that Blue Growth can or should offer to small-scale fisheries and coastal communities in the context of economic growth, employment and innovation.

Awtur estern

Kim Stobberup, María Dolores Garza Gil, Aude Stirnemann-Relot, Arthur Rigaud, Nicolò Franceschelli, Roland Blomeyer (Blomeyer & Sanz)

Focus on digital health events

01-06-2016

Digital health is high on the European and international agenda in June 2016, notably during eHealth Week from 8 to 10 June in Amsterdam, at the eHealth360°Summit from 14 to 16 June in Budapest and at the Digital Health World Congress on 22 and 23 June in London.

Digital health is high on the European and international agenda in June 2016, notably during eHealth Week from 8 to 10 June in Amsterdam, at the eHealth360°Summit from 14 to 16 June in Budapest and at the Digital Health World Congress on 22 and 23 June in London.

ISIL/Da'esh and 'non-conventional' weapons of terror

02-05-2016

The European Union and its Member States must prepare for the possibility of a chemical or biological attack on their territory by the self-styled 'Islamic State' in Iraq and the Levant (known variously as IS, ISIS or ISIL, and by the Arabic acronym 'Da'esh'). Since October 2015, terrorist attacks in Ankara, the Sinai Peninsula, Beirut, Paris, Tunis and Brussels, for which ISIL/Da'esh has claimed responsibility, have cost the lives of over 530 people. Immediately following the attacks in Paris and ...

The European Union and its Member States must prepare for the possibility of a chemical or biological attack on their territory by the self-styled 'Islamic State' in Iraq and the Levant (known variously as IS, ISIS or ISIL, and by the Arabic acronym 'Da'esh'). Since October 2015, terrorist attacks in Ankara, the Sinai Peninsula, Beirut, Paris, Tunis and Brussels, for which ISIL/Da'esh has claimed responsibility, have cost the lives of over 530 people. Immediately following the attacks in Paris and Brussels, the jihadist terrorist group threatened further attacks in European cities. ISIL/Da'esh has vowed that future strikes will be more lethal and even more shocking, prompting experts to warn that the group may be planning to try to use internationally banned weapons of mass destruction in future attacks. On 19 November 2015, the French Prime Minister, Manuel Valls, raised the spectre of ISIL/Da'esh planning a chemical or biological attack. At present, Europeans are generally not contemplating the possibility that extremist groups might use chemical, biological, radiological or nuclear (CBRN) materials during attacks in Europe. Under these circumstances, the impact of such an attack, should it occur, would be even more destabilising. European governments and EU institutions need to be on alert, and should consider publicly addressing the possibility of a terrorist attack using chemical, biological, radiological or even nuclear materials. The EU institutions have devoted considerable efforts to preventing a CBRN attack on European soil and preparing worst-case scenarios. However, some gaps remain, in particular with regard to information-sharing among Member States. This briefing updates the previous edition published on 3 December 2015.

Research for TRAN Committee – Self-Piloted Cars: The Future of Road Transport?

15-03-2016

The study provides an analysis of the development of automated vehicles inside and outside the EU, including both the technologies which are already on the market and those under testing and research. The EU is giving increasing attention to automated and connected vehicles as they could have huge impacts on road safety, travel behaviour and urban development. The study reports on state of the art key research projects and large scale testing in this area and discusses future pathways and potential ...

The study provides an analysis of the development of automated vehicles inside and outside the EU, including both the technologies which are already on the market and those under testing and research. The EU is giving increasing attention to automated and connected vehicles as they could have huge impacts on road safety, travel behaviour and urban development. The study reports on state of the art key research projects and large scale testing in this area and discusses future pathways and potential impacts of increasing vehicle automation. It concludes with recommendations on aspects that should be considered when shaping policies to sustain the research and development, and bringing to market, of highly automated and connected vehicles.

Awtur estern

Roberta Frisoni, Andrea Dall’Oglio, Craig Nelson, James Long, Christoph Vollath, Davide Ranghetti and Sarah McMinimy

Need for action on dementia recalled

12-02-2016

Dementia is one of Europe's biggest challenges in the context of demographic change. It has wide-ranging social and economic consequences for those living with the condition, their families and carers, and society as a whole. The Council's conclusions of December 2015 acknowledge the importance of this challenge. Dementia is not one specific disease, but an overall term for a syndrome that affects memory, thinking, orientation, comprehension, calculation, learning capacity, language and judgement ...

Dementia is one of Europe's biggest challenges in the context of demographic change. It has wide-ranging social and economic consequences for those living with the condition, their families and carers, and society as a whole. The Council's conclusions of December 2015 acknowledge the importance of this challenge. Dementia is not one specific disease, but an overall term for a syndrome that affects memory, thinking, orientation, comprehension, calculation, learning capacity, language and judgement. There are many different causes and forms of dementia. The condition remains little understood, and there is currently no cure. Action to tackle dementia is centred on its prevention, early detection and timely diagnosis, and on improving the quality of life of those living with it through care and support. Research focuses on the causes and possible treatments, on better care and prevention, as well as on developing assistive technologies. The European Commission has published a communication on dementia, undertaken various activities and funded research. A European Parliament resolution from 2011 called for dementia to be made a health priority. Major global dementia initiatives include a G8 declaration, the creation of the World Dementia Council, and the first Ministerial Conference on 'Global Action Against Dementia', hosted by the World Health Organization. Civil society is also actively involved.

How the EU budget is spent: Health Programme

09-12-2015

The European Union's third Health Programme for 2014-2020 is designed to complement, support and add value to the policies of the Member States to improve the health of EU citizens and reduce health inequalities, whilst respecting national autonomy in delivering health services and medical care. Its €449 million seven-year budget represents a substantial increase on the €321.5 million financial envelope for the 2008-2013 Health Programme.

The European Union's third Health Programme for 2014-2020 is designed to complement, support and add value to the policies of the Member States to improve the health of EU citizens and reduce health inequalities, whilst respecting national autonomy in delivering health services and medical care. Its €449 million seven-year budget represents a substantial increase on the €321.5 million financial envelope for the 2008-2013 Health Programme.

ISIL/Da'esh and 'non-conventional' weapons of terror

03-12-2015

The European Union and its Member States must prepare for the possibility of a chemical or biological attack on their territory by the self-styled 'Islamic State' in Iraq and the Levant (known variously as IS, ISIS or ISIL, and by the Arabic acronym 'Da'esh'). Since the beginning of October 2015, terrorist attacks in Ankara, the Sinai Peninsula, Beirut, Paris and Tunis, for which ISIL/Da'esh has claimed responsibility, have cost the lives of 500 people. Immediately following the latest attack in ...

The European Union and its Member States must prepare for the possibility of a chemical or biological attack on their territory by the self-styled 'Islamic State' in Iraq and the Levant (known variously as IS, ISIS or ISIL, and by the Arabic acronym 'Da'esh'). Since the beginning of October 2015, terrorist attacks in Ankara, the Sinai Peninsula, Beirut, Paris and Tunis, for which ISIL/Da'esh has claimed responsibility, have cost the lives of 500 people. Immediately following the latest attack in Paris, the jihadist terrorist group threatened further attacks in European cities. ISIL/Da'esh has vowed that future strikes will be more lethal and even more shocking. This has prompted experts to warn that the group may be planning to try to use internationally banned weapons of mass destruction in future attacks. On 19 November 2015, the French Prime Minister, Manuel Valls, raised the spectre of ISIL/Da'esh planning a chemical or biological attack. At present, European citizens are not seriously contemplating the possibility that extremist groups might use chemical, biological, radiological or nuclear (CBRN) materials during attacks in Europe. Under these circumstances, the impact of such an attack, should it occur, would be even more destabilising. European governments and EU institutions need to be on alert, and should consider publicly addressing the possibility of a terrorist attack using chemical, biological, radiological or even nuclear materials. The EU institutions have devoted considerable efforts to preventing a CBRN attack on European soil and preparing worst-case scenarios. However, some gaps remain, in particular with regard to information-sharing among Member States.

Personalised medicine: The right treatment for the right person at the right time

08-10-2015

'Personalised medicine' refers to a medical approach that uses molecular insights into health and disease to guide decisions with regard to the prediction, prevention, diagnosis and treatment of illnesses. Genetic factors play a role in most human diseases, with gene variations contributing to their incidence or course. New tools harnessed by personalised medicine include '-omics' technologies, which seek to define and explain the molecular mechanisms of the human body, and biomarkers, allowing us ...

'Personalised medicine' refers to a medical approach that uses molecular insights into health and disease to guide decisions with regard to the prediction, prevention, diagnosis and treatment of illnesses. Genetic factors play a role in most human diseases, with gene variations contributing to their incidence or course. New tools harnessed by personalised medicine include '-omics' technologies, which seek to define and explain the molecular mechanisms of the human body, and biomarkers, allowing us to subdivide patients into groups according to their likely response to a specific treatment, and so decide on the best-suited medication. Integrating advances in molecular technology into clinical practice comes with challenges, namely the translational gap, data protection, regulatory clarity and cost. Moreover, it is considered essential to educate patients (to acquire health literacy) as well as healthcare professionals (both in terms of providing them with undergraduate education and with continuous opportunities to advance their skills). EU initiatives in the field of personalised medicine include the Innovative Medicines Initiative (IMI), financial support to major research projects, and participation in international consortia. The Luxembourg Council Presidency has made personalised medicine one of its health priorities.

Assistive technologies to support people with disabilities

19-06-2015

'Disability' is complex and multi-dimensional. It denotes impairments, limitations on activity and restrictions on participation – a combination of medical and contextual factors. People with disabilities are a diverse group. Some are born with a disabling condition, others acquire a disability through injury or a chronic disease, yet others develop a disability in older age. The health needs of disabled people vary depending on the type of limitation and the primary health condition. Some may ...

'Disability' is complex and multi-dimensional. It denotes impairments, limitations on activity and restrictions on participation – a combination of medical and contextual factors. People with disabilities are a diverse group. Some are born with a disabling condition, others acquire a disability through injury or a chronic disease, yet others develop a disability in older age. The health needs of disabled people vary depending on the type of limitation and the primary health condition. Some may result in high healthcare needs, while others do not. On the whole, however, people with disabilities have a poorer health status than the general population. Several factors contribute to these health disparities. The way disability is addressed has shifted from a purely medical approach to one that focuses on maximum functioning and well-being. Assistive technologies to support people with disabilities have also evolved. They now cover sophisticated ICT, software, cyber-physical and stem-cell applications. A range of examples are provided from the five broad categories of motor, vision, hearing, cognitive and communication disabilities. They include non-invasive and invasive brain-computer interfaces, wearable devices, stem-cell applications, neuroprosthetics, humanoid robots and applications (apps). The EU has funded several research projects on the development of assistive technologies under its research and innovation framework programmes.

Avvenimenti fil-ġejjieni

05-11-2019
The Art and Craft of Political Speech-writing: A conversation with Eric Schnure
Avveniment ieħor -
EPRS
06-11-2019
Where next for Europe’s economy? The latest IMF European Regional Economic Outlook[.]
Avveniment ieħor -
EPRS
06-11-2019
EPRS Annual Lecture: Clash of Cultures: Transnational governance in post-war Europe
Avveniment ieħor -
EPRS

Sħab

Żomm ruħek konness

email update imageSistema ta' aġġornamenti bl-email

Permezz tas-sistema tat-twissija bl-email, li tibgħat l-aħħar informazzjoni direttament lill-indirizz tal-email tiegħek, inti tista' ssegwi l-persuni u l-avvenimenti kollha marbuta mal-Parlament. Dan jinkludi l-aħħar aħbarijiet dwar il-membri, is-servizzi tal-informazzjoni jew il-Grupp ta' Riflessjoni.

Is-sistema hija aċċessibbli minn kullimkien fuq il-websajt tal-Parlament. Biex tabbona u tirċievi notifiki tal-Grupp ta' Riflessjoni, kulma trid huwa li tagħti l-indirizz tal-email tiegħek, li tagħżel is-suġġett li jinteressak, li tindika l-frekwenza (kuljum, kull ġimgħa jew kull xahar) u li tikkonferma r-reġistrazzjoni tiegħek billi tikklikkja fuq il-link mibgħuta bl-email.

RSS imageTrażmissjonijiet RSS

M'hemm nieqsa l-ebda informazzjoni jew aġġornament fuq il-websajt tal-Parlament Ewropew bis-saħħa tal-flussi tagħna tal-RSS.

Jekk jogħġbok ikklikkja fuq il-link t'hawn taħt sabiex jiġi kkonfigurat il-fluss RSS tiegħek.